Asking the tuberculosis community to demand for more.
作者信息
Singh Alka Aggarwal
机构信息
Independent Public Health Consultant, Gurugram, India; Former Country Director, Vital Strategies, India; Former Senior Specialist, M&E, The Global Fund, Geneva.
出版信息
Indian J Tuberc. 2020 Oct;67(4):453-455. doi: 10.1016/j.ijtb.2020.07.008. Epub 2020 Jul 16.
PMID:33077042
Abstract
摘要
相似文献
1
Asking the tuberculosis community to demand for more.
Indian J Tuberc. 2020 Oct;67(4):453-455. doi: 10.1016/j.ijtb.2020.07.008. Epub 2020 Jul 16.
2
Stop TB Partnership has provided treatments for 10 million people in 6 years.
Wkly Epidemiol Rec. 2007 Jun 1;82(22/23):206-7.
3
Tuberculosis control goals unlikely to be met by 2005.
Lancet. 2004 Apr 3;363(9415):1122. doi: 10.1016/S0140-6736(04)15936-9.
4
[The prevention and treatment of tuberculosis in China: the present and the future].
Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):433-4.
5
[Romanian International Symposium of Pneumo-phtisiology, Călăraşi, May 15-16,2008].
Pneumologia. 2008 Jul-Sep;57(3):186-7.
6
Universal tuberculosis control targets: not so smart.
Int J Tuberc Lung Dis. 2009 Aug;13(8):923-4.
7
NIAID describes research priorities for fighting drug-resistant tuberculosis.
Home Healthc Nurse. 2008 Sep;26(8):448-9. doi: 10.1097/01.NHH.0000335598.63903.db.
8
The worldwide epidemic of multidrug-resistant tuberculosis.
Lancet Infect Dis. 2011 May;11(5):333. doi: 10.1016/S1473-3099(11)70105-0.
9
Stop the TB scourge.
S Afr Med J. 1996 Aug;86(8):897-8.
10
Drug resistance and tuberculosis elimination in low-incidence countries.
Eur Respir J. 2014 Dec;44(6):1408-11. doi: 10.1183/09031936.00138014.
Zotero 插件